Administration of cultured autologous bone marrow stromal cells into cerebrospinal fluid in spinal injury patients: A pilot study

Restorative Neurology and Neuroscience

Volumn 30, Issue 2, 2012, Pages 127-136

  Saito, Fukuki ^a   Nakatani, Toshio ^a   Iwase, Masaaki ^a   Maeda, Yuji ^a   Murao, Yoshinori ^a   Suzuki, Yoshihisa ^b   Fukushima, Masanori ^c   Ide, Chizuka ^d  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Kitano Hospital   (Japan)

^c Translational Research Informatics Center   (Japan)

^d AINO UNIVERSITY   (Japan)

Author keywords

bone marrow stromal cell; cerebrospinal fluid; Spinal cord injury treatment; spinal cord regeneration

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATINE KINASE; LACTATE DEHYDROGENASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BRAIN CONTUSION; CASE REPORT; CELL CULTURE; CELL SURFACE; CELL VIABILITY; CEREBROSPINAL FLUID; CERVICAL SPINE INJURY; CERVICAL SPINE RADIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; DECOMPRESSION; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTOSIS; MALE; MOTOR PERFORMANCE; NEURITE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PILOT STUDY; PRIORITY JOURNAL; QUADRIPLEGIA; SPINE FUSION; STROMA CELL; TREATMENT OUTCOME;

ADULT; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CEREBROSPINAL FLUID; CERVICAL VERTEBRAE; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; PILOT PROJECTS; SPINAL CORD INJURIES; SPINAL FUSION; STROMAL CELLS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859326618     PISSN: 09226028     EISSN: 18783627     Source Type: Journal    
DOI: 10.3233/RNN-2011-0629     Document Type: Article

References (33)

1. Attar, A., Ayten, M., Ozdemir, M., et al. (2011). An attempt to treat patients who have injured spinal cords with intralesional implantation of concentrated autologous bone marrow cells. Cytotherapy, 13, 54-60.
2. Bai, H., Suzuki, Y., Noda, T., et al. (2003). Dissemination and proliferation of neural stem cells on the spinal cord by injection into the fourth ventricle of the rat: A method for cell transplantation. J Neurosci Methods, 124, 181-187. (Pubitemid 36438627)
3. Bracken, M.B., Shepard, M.J., Collins, W.F., et al. (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. N Engl J Med, 322, 1405-1411.
4. Chernykh, E.R., Stupak, V.V., Muradov, G.M., et al. (2007). Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bull Exp Biol Med, 143, 543-547. (Pubitemid 47456600)
5. Deda, H., Inci, M.C., Kurekci, A.E., et al. (2008). Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. Cytotherapy, 10, 565-574.
6. Dobkin, B.H., Curt, A. & Guest, J. (2006). Cellular transplants in China: Observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair, 20, 5-13. (Pubitemid 43214453)
7. Fawcett, J.W., Curt, A., Steeves, J.D., et al. (2007). Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: Spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord, 45, 190-205. (Pubitemid 46340848)
8. Féron, F., Perry, C., Cochrane, J., et al. (2005). Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain, 128, 2951-2960. (Pubitemid 41746648)
9. Geisler, F.H., Coleman,W.P., Grieco, G., et al. (2001). Measurements and recovery patterns in a multicenter study of acute spinal cord injury. Spine, 26, S68-S86. (Pubitemid 34019782)
10. Geffner, L.F., Santacruz, P., Izurieta, M., et al. (2008). Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: Comprehensive case studies. Cell Transplant, 17, 1277-1293.
11. Grigoriadis, N., Lourbopoulos, A., Lagoudaki, R., et al. (2011).Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis. Exp Neurol, 230, 78-89.
12. Ha,Y., Park, H.S., Park,C.W., et al. (2005). Granulocyte macrophage colony stimulating factor (GM-CSF) prevents apoptosis and improves functional outcome in experimental spinal cord contusion injury. Clin Neurosurg, 52, 341-347.
13. Hagg,T.&Oudega,M. (2006).Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma, 23, 264-280. (Pubitemid 43726309)
14. Huang, H., Chen, L., Xi, H., et al. (2009). Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 23, 14- 20.
15. Ide, C., Nakai, Y., Nakano, N., et al. (2010). Bone marrow stromal cell transplantation for treatment of sub-acute spinal cord injury in the rat. Brain Res, 1332, 32-47.
16. Kishk, N.A., Gabr, H., Hamdy, S., et al. (2010). Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil Neural Repair, 24, 702-708.
17. Knoller, N., Auerbach, G., Fulga, V., et al. (2005). Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results. J Neurosurg Spine, 3, 173-181.
18. Kumar, A.A., Kumar, S.R., Narayanan, R., et al. (2009). Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Exp Clin Transplant, 7, 241-248.
19. Lima, C., Escada, P., Pratas-Vital, J., et al. (2006). Olfactory mucosa autografts in human spinal cord injury: A pilot clinical study. J Spin Cord Med, 29, 191-203.
20. Mackay-Sim, A., Féron, F., Cochrane, J., et al. (2008). Autologous olfactory ensheathing cell transplantation in human paraplegia: A 3-year clinical trial. Brain, 131, 2376-2386.
21. Nishida, H., Nakayama, M., Tanaka, H., et al. (2011). Evaluation of transplantation of autologous bone marrow stromal cells into the cerebrospinal fluid for treatment of chronic spinal cord injury in dogs. Am J Vet Res, 72, 1118-1123.
22. Ohori, Y., Yamamoto, S., Nagao, M., et al. (2006). Growth factor treatment and genetic manipulation stimulate neurogenesis and oligodendrogenesis by endogenous neural progenitors in the injured adult spinal cord. J Neurosci, 26, 11948-11960. (Pubitemid 44772106)
23. Ohta, M., Suzuki, Y., Noda, T., et al. (2004). Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol, 187, 266-278. (Pubitemid 38610273)
24. Pal, R., Venkataramana, N.K., Bansal, A., et al. (2009). Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: A pilot clinical study. Cytotherapy, 11, 897-911.
25. Saito, F., Nakatani, T., Iwase, M., et al. (2008). Spinal cord injury treatment with intrathecal autologous bone marrowstromal cell transplantation: The first clinical trial case report. J Trauma, 64, 53-59.
26. Syková, E., Homola, A., Mazanec, R., et al. (2006). Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplantation, 15, 675-687. (Pubitemid 46095251)
27. Vitellaro-Zuccarello, L., Mazzetti, S., Madaschi, L., et al. (2007). Erythropoietin-mediated preservation of the white matter in rat spinal cord injury. Neuroscience, 144, 865-877. (Pubitemid 46013988)
28. Waters, R.L., Adkins, R.H., Yakura, J.S., et al. (1993). Motor and sensory recovery following complete tetraplegia. Arch Phys Med Rehabil, 74, 242-247. (Pubitemid 23083796)
29. Wu, S., Suzuki, Y., Kitada, M., et al. (2001). Migration, integration, and differentiation of hippocampus-derived neurosphere cells after transplantation into injured rat spinal cord. Neurosci Lett, 312, 173-176. (Pubitemid 32972151)
30. Wu, S., Suzuki, Y., Kitada, M., et al. (2002). New method for transplantation of neurosphere cells into injured spinal cord through cerebrospinal fluid in rat. Neurosci Lett, 318, 81-84. (Pubitemid 34127692)
31. Wu, S., Suzuki, Y., Ejiri, Y., et al. (2003). Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. J Neurosci Res, 72, 343-351. (Pubitemid 36504703)
32. Yoon, S.H., Shim, Y.S., Park, Y.H., et al. (2007). Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trail. Stem Cells, 25, 2066-2073.
33. Young, W. (2002). Methylprednisolone and spinal cord injury. J Neurosurg, 96(Suppl 1), 141-142.